Cycloferon, 150 mg 50 pcs
€31.88 €29.56
Pharmgroup:
Antiviral and immunomodulatory drug. Inducer of interferon synthesis.
Pharmaceutical action:
Immunomodulator. Cycloferon® is a low molecular weight interferon inducer, which determines a wide range of its biological activity (antiviral, immunomodulatory, anti-inflammatory).
Cicliferon® is effective against herpes viruses, influenza and other pathogens of acute respiratory diseases.
It has direct antiviral action by suppressing viral reproduction at early stages (1-5 days) of the infection process, reducing the virulence of the viral progeny, resulting in the formation of defective viral particles. It increases nonspecific resistance of the organism against viral and bacterial infections.
Pharmacokinetics:
After oral administration of the drug in a daily dose, Cmax in plasma is reached after 2-3 hours, the concentration gradually decreases by 8 hours, after 24 hours the active substance is found in trace amounts.
The T1/2 is 4-5 hours. Administration of the drug Cycloferon® in recommended doses does not cause conditions for its cumulation in the body.
Indications
In adults in the treatment of: influenza and acute respiratory diseases; herpetic infection.
In children from four years of age in the treatment of: influenza and acute respiratory infections; herpetic infection.
In children from four years of age for the prevention of influenza and acute respiratory infections.
Active ingredient
Composition
1 tablet contains:
the active substance:
excipients:
povidone – 7.93 mg,
calcium stearate – 3.07 mg,
hypromellose – 2.73 mg,
polysorbate 80 – 0.27 mg,
methacrylic acid and ethyl acrylate copolymer – 23.21 mg,
propylene glycol – 1.79 mg.
How to take, the dosage
Orally once a day 30 minutes before a meal, without chewing, with ½ cup of water, in age dosages:
In children 4-6 years old: 150 mg (1 tablet) per dose;
children 7-11 years old: 300-450 mg (2-3 tablets) per dose;
adults and children over 12 years old: 450-600 mg (3-4 tablets) per dose.
It is reasonable to repeat the course 2-3 weeks after the first course.
In adults:
In the treatment of influenza and acute respiratory diseases the drug is taken on the 1st, 2nd, 4th, 6th, 8th day (treatment course of 20 tablets). Treatment shall be started at the first symptoms of the disease. With a severe course of the flu, six pills are taken on the first day. If necessary symptomatic therapy (antipyretic, analgesic, expectorants) shall be carried out additionally.
In case of herpetic infection the preparation is taken on the 1st, 2nd, 4th, 6th, 8th, 11th, 14th, 17th, 20th, 23rd day (treatment course – 40 tablets). The treatment is most effective when the first symptoms of the disease.
In children from four years:
In influenza and acute respiratory diseases the drug is taken in age-appropriate doses on 1, 2, 4, 6, 8, 11, 14, 17, 20, 23 days. The course of treatment consists of 5 to 10 shots depending on the severity of the condition and severity of clinical symptoms.
In case of herpes infection the drug is taken on the 1st, 2nd, 4th, 6th, 8th, 11th, 14th day of treatment. The course of treatment may vary depending on the severity of the condition and severity of clinical symptoms.
For emergency non-specific prevention of flu and acute respiratory diseases (in direct contact with a patient with flu or acute respiratory diseases of other etiology, during an epidemic of flu): on the 1st, 2nd, 4th, 6th, 8th day. After a break of 72 hours (three days) the course continues on the 11th, 14th, 17th, 20th, 23rd day. The total course consists of 5 to 10 doses.
Interaction
Special Instructions
Contraindications
Side effects
According to the World Health Organization, adverse effects are classified according to the frequency of their development as follows:
– very frequent (⥠1/10);
– frequent (⥠1/100 – < 1/10);
– infrequent (⥠1/1000 – < 1/100);
– rare (⥠1/10000 – < 1/1000);
– very rare (< 1/10000);
– frequency unknown (cannot be determined on the basis of available data).
Immune system disorders: very rare – angioedema. Skin and subcutaneous tissue disorders: very rare – rash, urticaria. If any of the adverse effects mentioned in the instructions are aggravated, or if you notice any other unwanted effects not specified in the instructions, inform your doctor.
Overdose
Symptoms: vomiting, drowsiness, tremor, excessive decrease in blood pressure, coma.
Treatment: gastric lavage, administration of activated charcoal, symptomatic therapy. There is no specific antidote.
Pregnancy use
Contraindicated.
Weight | 0.029 kg |
---|---|
Shelf life | 2 years |
Conditions of storage | In a light-protected place, at a temperature not exceeding 25 °C |
Manufacturer | Polysan NTFF LLC, Russia |
Medication form | enteric-soluble film-coated tablets |
Brand | Polysan NTFF LLC |
Other forms…
Related products
Buy Cycloferon, 150 mg 50 pcs with delivery to USA, UK, Europe and over 120 other countries.